Expression of Inducible Nitric Oxide Synthase in Rat Experimental Autoimmune Myocarditis With Special Reference to Changes in Cardiac Hemodynamics
Authors:
- 1 January 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 80 (1) , 11-20
Abstract
Excessive NO produced by an inducible NO synthase (iNOS) has been implicated in many types of immune-associated disorders of the cardiovascular system, but it remains to be determined whether NO plays a role in myocarditis. Thus, the significance of iNOS expression in the development of experimental autoimmune myocarditis (EAM), an animal model of human giant cell myocarditis, was investigated. Lewis rats were immunized with cardiac myosin and were killed 7, 14, 21, 28, and 49 days after immunization. The development of severe myocarditis was observed on days 14, 21, and 28 in association with significant deterioration of hemodynamics determined by cardiac catheterization, which peaked on day 21. In parallel with histological severity of myocarditis and deterioration of cardiac performance, iNOS activity in the heart measured by [14C]l-citrulline formation was markedly increased on days 14, 21, and 28. The expression of iNOS was confirmed by immunoblotting and was localized to the infiltrating inflammatory cells found in the vicinity of necrotic myocytes by immunohistochemical analysis. Aminoguanidine, a selective inhibitor of iNOS, significantly decreased the iNOS activity (1.04±0.37 compared with 29.1±8.62 pmol·min−1·mg protein−1in untreated myosin-immunized rats,P<.01) and effectively attenuated histopathological changes of EAM on day 21. Hemodynamic parameters were also improved from 64±3 to 89±3 mm Hg for mean blood pressure, from 80±2 to 113±4 mm Hg for left ventricular systolic pressure, from 7.8±0.3 to 3.2±0.3 mm Hg for left ventricular end-diastolic pressure, from 2867±137 to 4180±102 mm Hg/s for +dP/dt, and from 2717±132 to 4180±184 mm Hg/s for −dP/dt (P<.01). The values after aminoguanidine treatment were not significantly different from the control values. These results suggest an important role for NO in mediating pathophysiological changes in myocarditis of autoimmune origin.Keywords
This publication has 48 references indexed in Scilit:
- Induction of myocardial nitric oxide synthase by cardiac allograft rejection.Journal of Clinical Investigation, 1994
- Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice.Journal of Clinical Investigation, 1994
- Modulation of myocardial contraction by endocardial and coronary vascular endotheliumTrends in Cardiovascular Medicine, 1993
- An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in ratsClinical Immunology and Immunopathology, 1992
- Nitric oxide: a pathogenetic factor in autoimmunityImmunology Today, 1992
- A novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fractionClinical Immunology and Immunopathology, 1990
- Murine cytotoxic activated macrophages inhibit aconitase in tumor cells. Inhibition involves the iron-sulfur prosthetic group and is reversible.Journal of Clinical Investigation, 1986
- Coxsackievirus myocarditis—With special reference to acute and chronic effectsProgress in Cardiovascular Diseases, 1985
- Active Myocarditis in the Spectrum of Acute Dilated CardiomyopathiesNew England Journal of Medicine, 1985
- Distribution and properties of human intestinal diamine oxidase and its relevance for the histamine catabolismBiochimica et Biophysica Acta (BBA) - General Subjects, 1983